Reference 2018-684

REF:           2018-684

Subject:       Trust Zoledronic acid coding

 

Request:

Question 1

What is the OPCS code in your Trust for the delivery of Zoledronic acid 5 mg for the treatment of osteoporosis in post-menopausal women and adult men at increased risk of fracture?

 

Question 2

What is the corresponding HRG code that would relate to the OPCS code from Information request 1 for the outpatient delivery of Zoledronic acid 5 mg for the treatment of osteoporosis in post-menopausal women and adult men at increased risk of fracture in your Trust?

 

Question 3

What is the OPCS code in your Trust for the delivery of Zoledronic acid 4 mg for the prevention of skeletal related events in adult patients with advanced malignancies involving bone or tumour-induced hypercalcaemia?

 

Question 4

What is the corresponding HRG code that would relate to the OPCS code from Information request 3 for the outpatient delivery of Zoledronic acid 4 mg for patients with advanced malignancies involving bone in your Trust?

 

 

Response:

It is not possible to identify the use of this drug through coding.